BRPI0414941A - dispositivo de distribuição de agente ativo acionado osmoticamente proporcionando um perfil de liberação ascendente - Google Patents

dispositivo de distribuição de agente ativo acionado osmoticamente proporcionando um perfil de liberação ascendente

Info

Publication number
BRPI0414941A
BRPI0414941A BRPI0414941-6A BRPI0414941A BRPI0414941A BR PI0414941 A BRPI0414941 A BR PI0414941A BR PI0414941 A BRPI0414941 A BR PI0414941A BR PI0414941 A BRPI0414941 A BR PI0414941A
Authority
BR
Brazil
Prior art keywords
active agent
rate
osmotic pump
controlling membrane
osmotic
Prior art date
Application number
BRPI0414941-6A
Other languages
English (en)
Inventor
Guohua Chen
Rupal A Ayer
Scott Lautenbach
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of BRPI0414941A publication Critical patent/BRPI0414941A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. by means of pistons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. by means of pistons
    • A61M2005/14513—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. by means of pistons with secondary fluid driving or regulating the infusion

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

"DISPOSITIVO DE DISTRIBUIçãO DE AGENTE ATIVO ACIONADO OSMOTICAMENTE PROPORCIONANDO UM PERFIL DE LIBERAçãO ASCENDENTE". Em um aspecto, a presente invenção é dirigida a uma bomba osmótica, que proporciona, automaticamente, uma taxa de liberação ascendente de agente ativo, na medida em que a bomba osmótica funciona em um meio físico de operação, e pode ser projetada para implante dentro de um paciente animal ou humano desejado. Uma bomba osmótica, de acordo com a presente invenção, inclui um reservatório, uma membrana controladora de taxa, uma composição osmótica expansível, uma formulação de agente ativo e um orifício de saída. Uma vez administrada a um meio físico de operação, a água passa pela membrana controladora de taxa e para a composição osmótica, o que faz com que a composição osmótica se expanda e expila a formulação de agente ativo pelo orifício de saída, a uma taxa que é diretamente proporcional à taxa na qual a água passa pela membrana controladora de taxa. Uma bomba osmótica de acordo com a presente invenção permite que o fluxo de água pela membrana controladora de taxa aumente automaticamente, sem a necessidade de manipulação da bomba osmótica, após administração. Na medida em que o fluxo de água pela membrana controladora de taxa aumenta, a taxa na qual a formulação de agente ativo é distribuída da bomba osmótica vai também aumentar proporcionalmente.
BRPI0414941-6A 2003-09-30 2004-09-29 dispositivo de distribuição de agente ativo acionado osmoticamente proporcionando um perfil de liberação ascendente BRPI0414941A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50792003P 2003-09-30 2003-09-30
PCT/US2004/031983 WO2005032524A2 (en) 2003-09-30 2004-09-29 Osmotically driven active agent delivery device providing an ascending release profile

Publications (1)

Publication Number Publication Date
BRPI0414941A true BRPI0414941A (pt) 2006-11-07

Family

ID=34421688

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0414941-6A BRPI0414941A (pt) 2003-09-30 2004-09-29 dispositivo de distribuição de agente ativo acionado osmoticamente proporcionando um perfil de liberação ascendente

Country Status (12)

Country Link
US (1) US7241457B2 (pt)
EP (1) EP1682099A2 (pt)
JP (1) JP2007507513A (pt)
KR (1) KR20060097008A (pt)
CN (1) CN1859900A (pt)
AU (1) AU2004277980A1 (pt)
BR (1) BRPI0414941A (pt)
CA (1) CA2538043A1 (pt)
IL (1) IL174294A0 (pt)
MX (1) MXPA06002967A (pt)
WO (1) WO2005032524A2 (pt)
ZA (1) ZA200603420B (pt)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7919109B2 (en) 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
US7731947B2 (en) * 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
US20050266087A1 (en) * 2004-05-25 2005-12-01 Gunjan Junnarkar Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
US20060020253A1 (en) * 2004-07-26 2006-01-26 Prescott Anthony D Implantable device having reservoir with controlled release of medication and method of manufacturing the same
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US7959938B2 (en) 2005-03-15 2011-06-14 Intarcia Therapeutics, Inc. Polyoxaester suspending vehicles for use with implantable delivery systems
JP5265359B2 (ja) 2005-08-11 2013-08-14 マサチューセッツ インスティテュート オブ テクノロジー 膀胱内薬物送達デバイスおよび方法
EP1818664B1 (de) 2006-02-13 2013-05-01 F.Hoffmann-La Roche Ag Vorrichtung zur Erkennung einer Druckänderung im Flüssigkeitspfad einer Mikrodosiervorrichtung
EP2020990B1 (en) 2006-05-30 2010-09-22 Intarcia Therapeutics, Inc Two-piece, internal-channel osmotic delivery system flow modulator
PL2359808T3 (pl) 2006-08-09 2013-10-31 Intarcia Therapeutics Inc Osmotyczne systemy dostawcze i zespoły tłokowe
US8641660B2 (en) * 2006-10-04 2014-02-04 P Tech, Llc Methods and devices for controlling biologic microenvironments
US8617143B2 (en) * 2006-12-07 2013-12-31 The Regents Of The University Of California Therapeutic agent delivery systems and devices
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
CA2682432C (en) 2007-03-30 2017-06-06 Duke University Device and method for delivery of a medicament
EP2157967B1 (en) 2007-04-23 2013-01-16 Intarcia Therapeutics, Inc Suspension formulations of insulinotropic peptides and uses thereof
TWI454288B (zh) 2008-01-25 2014-10-01 Gruenenthal Chemie 藥物劑型
EP2240155B1 (en) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Devices, formulations, and methods for delivery of multiple beneficial agents
ES2599031T3 (es) 2008-05-09 2017-01-31 Grünenthal GmbH Proceso para la preparación de una formulación de polvo intermedia y una forma de dosificación solida final utilizando un paso de congelación por pulverización
EA201170297A1 (ru) 2008-08-09 2011-08-30 Массачусетс Инститьют Оф Текнолоджи Имплантируемое устройство для доставки лекарственных средств и способ лечения мужской мочеполовой системы и окружающих тканей
CN104013569A (zh) * 2008-10-15 2014-09-03 精达制药公司 高浓缩药物颗粒、制剂、混悬剂及其应用
US20100155333A1 (en) * 2008-12-18 2010-06-24 Chevron U.S.A., Inc. Process for dewatering an aqueous organic solution
BR112012001466A2 (pt) 2009-07-22 2020-08-11 Grünenthal GmbH forma de dosagem resistente à falsificação para opioides sensíveis à oxidação, seu processo de fabricação, e embalagem
ES2534908T3 (es) 2009-07-22 2015-04-30 Grünenthal GmbH Forma de dosificación de liberación controlada extruida por fusión en caliente
EP3323423B1 (en) * 2009-09-28 2020-06-17 Intarcia Therapeutics, Inc Rapid establishment and/or termination of substantial steady-state drug delivery
JP2013540464A (ja) 2010-08-30 2013-11-07 サイナシス コーポレーション 副鼻腔開口部を拡張するため、および副鼻腔炎を治療するためのデバイスおよび方法
WO2012028318A1 (en) 2010-09-02 2012-03-08 Grünenthal GmbH Tamper resistant dosage form comprising an anionic polymer
CA2808219C (en) 2010-09-02 2019-05-14 Gruenenthal Gmbh Tamper resistant dosage form comprising inorganic salt
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9351924B2 (en) * 2011-03-11 2016-05-31 Snu R&Db Foundation Drug delivery system including laminated structure
BR112014002022A2 (pt) 2011-07-29 2017-02-21 Gruenenthal Gmbh comprimido resistente à violação proporcionando liberação de fármaco imediata
JP6063462B2 (ja) 2011-07-29 2017-01-18 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 即時薬剤放出を提供するタンパーレジスタント錠剤
BR112014019988A8 (pt) 2012-02-28 2017-07-11 Gruenenthal Gmbh Forma de dosagem resistente a socamento compreendendo um composto farmacologicamente ativo e um polímero aniônico
US9138569B2 (en) 2012-02-29 2015-09-22 SinuSys Corporation Devices and methods for dilating a paranasal sinus opening and for treating sinusitis
LT2838512T (lt) 2012-04-18 2018-11-12 GrĆ¼nenthal GmbH Pažeidimui atspari ir dozės atpalaidavimo nuokrypiui atspari farmacinė vaisto forma
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
US9814671B2 (en) 2013-03-15 2017-11-14 Taris Biomedical Llc Drug delivery devices and methods for drug delivery
HUE072250T2 (hu) 2013-03-15 2025-11-28 Taris Biomedical Llc Gyógyszeradagoló eszközök gyógyszeráteresztõ résszel
AU2014273227B2 (en) 2013-05-29 2019-08-15 Grunenthal Gmbh Tamper-resistant dosage form containing one or more particles
MX2015016254A (es) 2013-05-29 2016-04-20 Gruenenthal Gmbh Forma de dosificacion resistente al uso indebido con perfil de liberacion bimodal.
US9687263B2 (en) 2013-05-30 2017-06-27 SinuSys Corporation Devices and methods for inserting a sinus dilator
AU2014289187B2 (en) 2013-07-12 2019-07-11 Grunenthal Gmbh Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
ES2956840T3 (es) 2013-08-19 2023-12-29 Taris Biomedical Llc Dispositivos de administración de fármacos de múltiples unidades
HK1224189A1 (zh) 2013-11-26 2017-08-18 Grünenthal GmbH 通过低温研磨制备粉状药物组合物
WO2015173195A1 (en) 2014-05-12 2015-11-19 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
US9872835B2 (en) 2014-05-26 2018-01-23 Grünenthal GmbH Multiparticles safeguarded against ethanolic dose-dumping
CN106714871A (zh) * 2014-06-25 2017-05-24 魏民 用于给药的输液装置
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
KR102658706B1 (ko) 2015-04-23 2024-04-17 타리스 바이오메디컬 엘엘씨 약물-투과성 성분을 구비한 약물 전달 장치 및 방법
WO2016170097A1 (en) 2015-04-24 2016-10-27 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
ES2968262T3 (es) 2015-06-03 2024-05-08 I2O Therapeutics Inc Sistemas de colocación de implantes
CA2998259A1 (en) 2015-09-10 2017-03-16 Grunenthal Gmbh Protecting oral overdose with abuse deterrent immediate release formulations
KR20240037175A (ko) 2016-05-16 2024-03-21 인타르시아 세라퓨틱스 인코포레이티드 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
AU2018206539A1 (en) 2017-01-03 2019-07-18 Intarcia Therapeutics, Inc. Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
SMT202100310T1 (it) 2017-02-01 2021-07-12 Taris Biomedical Llc Dispositivi per la deposizione di farmaci in vivo
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly
CN109589491B (zh) * 2019-01-29 2024-01-09 上海安翰医疗技术有限公司 自动给药装置
JP2025176720A (ja) * 2022-10-07 2025-12-05 テルモ株式会社 薬剤投与装置
JP2026079829A (ja) * 2023-03-30 2026-05-18 テルモ株式会社 投与装置、及び被投与物の投与状態の判断方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3625214A (en) * 1970-05-18 1971-12-07 Alza Corp Drug-delivery device
US4874388A (en) 1987-06-25 1989-10-17 Alza Corporation Multi-layer delivery system
US4976966A (en) * 1988-12-29 1990-12-11 Alza Corporation Delayed release osmotically driven fluid dispenser
US5234693A (en) 1990-07-11 1993-08-10 Alza Corporation Delivery device with a protective sleeve
GB9027422D0 (en) 1990-12-18 1991-02-06 Scras Osmotically driven infusion device
US5288214A (en) 1991-09-30 1994-02-22 Toshio Fukuda Micropump
US5639477A (en) 1993-06-23 1997-06-17 Alza Corporation Ruminal drug delivery device
DE69529572T2 (de) 1994-11-10 2003-06-18 The University Of Kentucky Research Foundation, Lexington Implantierbare wiederauffüllbare vorrichtung mit gesteuerter freisetzung zur verabreichung von arzneistoffen unmittelbar an einen inneren teil des körpers
US6261584B1 (en) 1996-02-02 2001-07-17 Alza Corporation Sustained delivery of an active agent using an implantable system
US6132420A (en) * 1996-02-02 2000-10-17 Alza Corporation Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems
DE69720190T2 (de) 1996-02-02 2003-12-11 Alza Corp Implantierbares system mit verzögerter freisetzung von leuprolid
US5976109A (en) 1996-04-30 1999-11-02 Medtronic, Inc. Apparatus for drug infusion implanted within a living body
ZA981610B (en) 1997-03-24 1999-08-26 Alza Corp Self adjustable exit port.
MY125849A (en) 1997-07-25 2006-08-30 Alza Corp Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems
CA2315890C (en) 1997-12-22 2009-08-11 Alza Corporation Rate controlling membranes for controlled drug delivery devices
EP1041968B1 (en) * 1997-12-29 2004-03-03 Alza Corporation Osmotic delivery system with membrane plug retention mechanism
ATE342051T1 (de) 1997-12-30 2006-11-15 Alza Corp Verabreichungssystem für wirkstoffe mit einem membranstöpsel
US6245357B1 (en) * 1998-03-06 2001-06-12 Alza Corporation Extended release dosage form
US6436091B1 (en) 1999-11-16 2002-08-20 Microsolutions, Inc. Methods and implantable devices and systems for long term delivery of a pharmaceutical agent
US6283949B1 (en) 1999-12-27 2001-09-04 Advanced Cardiovascular Systems, Inc. Refillable implantable drug delivery pump
US6464688B1 (en) 2000-02-15 2002-10-15 Microsolutions, Inc. Osmotic pump delivery system with flexible drug compartment
US6471688B1 (en) 2000-02-15 2002-10-29 Microsolutions, Inc. Osmotic pump drug delivery systems and methods

Also Published As

Publication number Publication date
JP2007507513A (ja) 2007-03-29
US20050107772A1 (en) 2005-05-19
MXPA06002967A (es) 2006-06-14
CN1859900A (zh) 2006-11-08
WO2005032524A2 (en) 2005-04-14
IL174294A0 (en) 2006-08-01
US7241457B2 (en) 2007-07-10
CA2538043A1 (en) 2005-04-14
ZA200603420B (en) 2007-07-25
WO2005032524A3 (en) 2005-05-26
AU2004277980A1 (en) 2005-04-14
EP1682099A2 (en) 2006-07-26
KR20060097008A (ko) 2006-09-13

Similar Documents

Publication Publication Date Title
WO2005032524A3 (en) Osmotically driven active agent delivery device providing an ascending release profile
ES2208931T3 (es) Composicion farmaceutica basada en agua.
BRPI0502220A (pt) Distribuidor de água de fluxo variável para congeladores de refrigerador
DE60228293D1 (de) Implantierbare vorrichtungen zur behandlung von schmerzen durch abgabe von fentanyl und fentanyl-verwandten
NO915043L (no) Osmoseanordning for kontrollert avgivelse av et nyttig middel
WO2000020056A8 (en) Patient controlled fluid delivery device
ES2041174T3 (es) Sistema intravenoso para suministrar un agente beneficioso.
AR040245A1 (es) Formas de dosificacion y composiciones para administracion osmotica de dosificaciones variables de oxicodone
AR020288A1 (es) Emulsion aceite en agua que comprende un agente biologicamente activo micronizado y un sistema emulsionante adecuado.
MXPA04002476A (es) Dispositivo de nanoporo microfabricado para la liberacion sostenida de agente terapeutico.
AR033066A1 (es) Metodo para controlar la liberacion de ingredientes activos agricolas desde semillas de plantas tratadas
BR0113387A (pt) Distribuidor de produto fluido com bomba integrada
DE60230888D1 (de) Modulare vorrichtung zur verabreichung von medikamenten
BR0205990A (pt) Um sistema implantável de liberação unidirecional de agentes terapêuticos para tecidos
MXPA05007785A (es) Sistemas dosificadores de cosmeticos y/o farmaceuticos topicos.
ATE366592T1 (de) Implantierbare pumpe mit einstellbarer förderrate
BRPI0516718B8 (pt) formulação de liberação modificada de ibuprofeno fornecendo liberação imediata e prolongada do fármaco
CL2010000232A1 (es) Combinacion fungicida que comprende fluxastrobin y boscalid y usos de la misma para combatir hongos fitopatogenos indeseados y en la obetencion de composiciones fungicidas que comprenden ademas agentes extendedores y/o surfactantes (divisional sol. 2673-05).
Monton et al. The preparation, characterization, and stability evaluation of a microemulsion-based oral spray containing clove oil for the treatment of oral candidiasis
WO2011107221A1 (de) Vorrichtung und verfahren zur verwendung zur körperflege, insbesondere beim duschen, baden oder händewaschen
HRP20221252T1 (hr) Sustavi isporuke lijeka i postupci za liječenje raka mokraćnog mjehura s gemcitabinom
ATE268162T1 (de) Selbstemulgierendes arzneistoffverabreichungssystem, wobei das fettmittel optional ist
HRP20211921T1 (hr) Sustavi isporuke lijeka i postupci za liječenje raka mokraćnog mjehura s oksaliplatinom
ES2059495T3 (es) Dispositivo de descarga de farmacos regulado por solubilidad.
BR112018000039A2 (pt) dispositivo de liberação de uso único

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADE(S)

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011.